SMSbiotech and CCRM Australia forges strategic collaboration

CCRM Australia is proud to announce a strategic collaboration with SMS Biotech Inc. to provide strategic and commercial advisory services to its Australian subsidiary SMSbiotech Australia Pty Ltd.

SMSbiotech, headquartered in San Diego, is an innovative regenerative medicine pioneering advanced therapies through its proprietary platform technology. Their pipeline spans multiple therapeutic areas, including respiratory disease. SMSbiotech currently has a candidate in Phase 1 Clinical Trial in Australia and is exploring opportunities to operationalise and expand its activities within Australia. As part of this collaboration, CCRM Australia will join forces with SMSbiotech to develop and implement commercialisation strategies, supporting SMSbiotech’s growth and expanding its global footprint.